Does Uterine Fibroids Affect IVF in Thailand? Professional Medical Evaluation & Management Guide

Opening: Real Consultation Scenario

"Doctor, I found a uterine fibroid during my check-up, about 3.5cm. I plan to go to Thailand for PGT. Will this fibroid affect the success rate? Do I need surgery first?"
This is the type of consultation I encounter weekly in my overseas reproductive medicine coordination work. Patients often come with ultrasound reports, worried that the fibroid will hinder their chances of a successful pregnancy, yet also afraid that surgery will delay their timeline. Today, I will break down this issue clearly from a reproductive medicine perspective.

Direct Answer: Whether Fibroids Affect IVF Depends on Three Dimensions

Whether uterine fibroids affect IVF outcomes does not depend on "having fibroids or not," but on three core variables: location, size, and type. Approximately 20% to 40% of women of reproductive age have uterine fibroids, and the vast majority of fibroid carriers can safely complete the IVF process and achieve good pregnancy rates.

Below is the most commonly used clinical assessment framework:

So the answer is clear: Subserosal fibroids and most intramural fibroids ≤4cm that do not compress the endometrium generally do not affect IVF in Thailand; submucosal fibroids and intramural fibroids that compress the uterine cavity must be treated before starting the cycle.

Doctor's Perspective: Why the Same Fibroid Affects Different People Differently

In the clinic, I often use the "soil and seed" analogy — the endometrium is the soil for embryo implantation, and fibroids are like stones in the soil. If the stone is buried deep (subserosal), the soil surface remains flat, and the seed can root normally; if the stone is on the surface (submucosal), the soil becomes uneven, making it difficult for the seed to anchor.

But clinical reality is more complex than the analogy. The mechanisms by which fibroids affect endometrial receptivity include:

• Mechanical Compression: Fibroids occupy space in the uterine cavity, directly compressing the endometrial area and affecting blood supply.
• Local Inflammatory Microenvironment: Fibroid tissue releases inflammatory factors, interfering with endometrial immune regulation and decidualization.
• Hormonal Sensitivity: Fibroid cells express estrogen and progesterone receptors, and may enlarge due to hormonal fluctuations during ovarian stimulation.
• Abnormal Uterine Contractions: Large fibroids may alter the frequency and direction of uterine contractions, affecting embryo positioning.

Therefore, assessment cannot rely solely on the "fibroid size" from an ultrasound report. It must combine fibroid location, uterine cavity shape, endometrial thickness and blood flow, patient age, and ovarian reserve for a comprehensive judgment.

Why Does the Impact of Fibroids Vary So Much by Location?

The anatomical structure of the uterus determines that the core area for embryo implantation is the endometrial cavity. Submucosal fibroids directly alter the shape of the uterine cavity, creating a bulge on an otherwise flat surface, making it difficult for the embryo to attach at the bulge or its edges. Even if implantation occurs, abnormal local blood supply can easily lead to early miscarriage.

The impact of intramural fibroids depends on the "fibroid-endometrium distance." A 2021 meta-analysis including over 2000 IVF cycles showed: When the fibroid edge is less than 5mm from the endometrium, the clinical pregnancy rate drops by about 30%; when the distance is greater than 5mm, the pregnancy rate is not significantly different from women without fibroids. Therefore, not all intramural fibroids need treatment; the key is whether they are "close" to the endometrium.

Subserosal fibroids grow outward and do not interfere with the uterine cavity shape or endometrial blood supply, so they generally have no negative impact on IVF outcomes. These patients can typically proceed with the standard protocol without additional intervention.

Key Diagnostic Tests: How to Accurately Assess the Impact of Fibroids on IVF

Before going to Thailand for IVF, the following tests are necessary for evaluating fibroids. Each has clear clinical significance:

For patients planning IVF in Thailand, I recommend completing the above core tests in your home country first, then sending the reports to the Thai fertility center for a pre-assessment. This allows you to determine in advance whether fibroid surgery is needed, avoiding wasted time and money upon arrival in Thailand.

Special Pathway for Fibroid Patients in the Thai IVF Process

Thai fertility centers follow internationally accepted evidence-based principles for managing fibroid patients, but there are several notable features in their process:

Step 1: Remote Pre-Assessment (Completed in Home Country)

• Submit ultrasound/hysteroscopy/AMH reports to the Thai doctor; an assessment is usually provided within 3-5 working days.
• The doctor will clearly advise: whether surgery is needed, whether you can proceed directly to the cycle, and which stimulation protocol to use.

Step 2: Pretreatment Phase (If Surgery is Needed)

• Submucosal fibroids: Perform hysteroscopic myomectomy in Thailand or your home country, then rest for 2-3 menstrual cycles before starting IVF.
• Intramural fibroids compressing the endometrium: GnRH agonists (e.g., leuprolide) can be injected for 2-3 months to shrink the fibroid before starting the cycle.
• Some Thai centers also offer High-Intensity Focused Ultrasound (HIFU) treatment for specific types of intramural fibroids.

Step 3: Ovarian Stimulation and Egg Retrieval

• Fibroid patients typically respond to stimulation medications similarly to others, but fibroid size changes should be monitored during ultrasound checks.
• In about 15% to 20% of patients, fibroids may slightly enlarge (average 0.5-1.5cm) due to elevated estrogen levels during stimulation. They usually return to original size after medication stops; no need for excessive concern.

Step 4: Embryo Culture and PGT

• Thailand has advanced PGT technology. For fibroid patients, performing Preimplantation Genetic Testing for Aneuploidy (PGT-A) can select chromosomally normal embryos, partially compensating for the impact of fibroids on implantation rates.
• However, PGT cannot solve uterine environment issues. If the fibroid itself compresses the endometrium, even normal embryos will have a low implantation rate.

Step 5: Timing of Frozen Embryo Transfer

• For fibroid patients, Frozen Embryo Transfer (FET) is recommended over fresh cycle transfer.
• Reason: High hormone levels after stimulation may stimulate fibroid growth. FET allows better control of the hormonal environment in a natural or artificial cycle, selecting the window period when fibroid volume is smallest for transfer.

Easily Overlooked Detail: Fibroids May "Quietly Grow" During Ovarian Stimulation

Many patients focus only on fibroid size at the time of transfer, overlooking changes during the stimulation phase. We reviewed data from IVF cycles of fibroid patients in Thailand over the past two years and found:

• Average fibroid volume increases by about 12% to 18% during stimulation, with some sensitive individuals experiencing growth of over 30%.
• This increase is usually temporary; fibroids return to their original size after egg retrieval as hormone levels drop.
• However, if a fibroid is already close to the endometrium, growth during stimulation may further compress the endometrium, affecting subsequent transfer.

Therefore, I recommend that fibroid patients measure fibroid size on stimulation days 5, 8, and the trigger day, and record the results. If a fibroid grows rapidly and compresses the endometrium, discuss with your doctor whether to cancel the fresh transfer and opt for freezing all embryos.

Three Common Pitfalls to Avoid

In cross-border IVF consultations, I have noticed the following recurring issues. I hope patients about to embark on this journey can avoid them:

Pitfall 1: Starting the Cycle Without a Hysteroscopy

Ultrasound cannot always 100% determine if a fibroid protrudes into the uterine cavity. I once had a patient whose ultrasound in Thailand suggested an intramural fibroid, but a hysteroscopy before transfer after egg retrieval revealed it was actually a submucosal fibroid (Type II). The transfer had to be cancelled for surgery first. If she had undergone hysteroscopy in her home country, this wasted trip could have been avoided.

Pitfall 2: Rushing into Transfer Immediately After Fibroid Surgery

After hysteroscopic myomectomy, the uterus needs time to heal. It is generally recommended to rest for 2-3 menstrual cycles before starting IVF, allowing the endometrium to fully heal and restore normal receptivity. Some patients, worried about age, start stimulation just one month after surgery, only to face transfer failure due to poor endometrial receptivity.

Pitfall 3: Ignoring Male Factors

Fibroid patients often focus all their attention on themselves, neglecting male sperm quality. In reality, about 40% of transfer failures in fibroid patients are due to embryonic factors, not uterine factors. Before going to Thailand, the male partner must complete semen analysis + sperm DNA fragmentation index (DFI) testing. If DFI >25%, it is advisable to first address the issue or consider ICSI combined with PGT.

Special Case Management: Multiple Fibroids, Coexisting Adenomyosis, Advanced Age

Multiple Fibroids (≥3)

The principle for managing multiple fibroids is "treat the main culprit" — only address fibroids that affect the uterine cavity shape or compress the endometrium; leave others untouched. Removing too many fibroids surgically can damage the uterine muscle, reducing uterine receptivity. Thai doctors often use GnRH agonist pretreatment for 2-3 months to shrink all fibroids simultaneously before starting the cycle, which is more effective than individual surgeries.

Fibroids Coexisting with Adenomyosis

This is a more complex situation. Adenomyosis itself reduces endometrial receptivity, and the combined effect with fibroids further lowers pregnancy rates. For these patients, I recommend:

• First, perform a pelvic MRI to determine the extent and depth of adenomyosis.
• GnRH agonist injections for 3-4 months to improve both adenomyosis and shrink fibroids.
• Prioritize frozen embryo transfer, using a hormone replacement protocol in the transfer cycle to control uterine contractions.
• If repeated transfers fail, evaluate whether adenomyosis lesion resection is needed.

Advanced Age (≥38 years) + Fibroids

For older patients, ovarian reserve is a "scarce resource" and time cannot be spent waiting for fibroid surgeries. The clinical pathway for older patients with fibroids is:

• If the fibroid does not affect the uterine cavity (subserosal or intramural far from the endometrium), proceed directly to egg retrieval and embryo accumulation.
• If the fibroid does affect the uterine cavity, prioritize GnRH agonist injections (no surgery) to improve the uterine environment within 2-3 months.
• Perform PGT-A on all embryos to select chromosomally normal ones for transfer, maximizing the efficiency of each transfer.

Simply put: Older patients are racing against time; use non-surgical methods to create conditions for IVF whenever possible.

This article is written by a reproductive medicine specialist, based on clinical consensus in assisted reproduction (2023-2025) and real case summaries. It does not constitute personal medical advice. For specific diagnosis and treatment, please make decisions jointly with your fertility center doctor.